On May 29, 2024 Neurocrine Biosciences, Inc. (Nasdaq: NBIX) reported that it will participate at two upcoming investor conferences in June (Press release, Neurocrine Biosciences, MAY 29, 2024, View Source [SID1234643795]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Kevin Gorman, Chief Executive Officer, Kyle Gano, Chief Business Development and Strategy Officer, and Matt Abernethy, Chief Financial Officer will present at the Jefferies Global Healthcare Conference at 2:30 p.m. Eastern Time on Wednesday June 5, 2024 in New York.
Kevin Gorman and Kyle Gano will present at the Goldman Sachs 45th Annual Global Healthcare Conference at 10:40 a.m. Eastern Time on Thursday June 13, 2024 in Miami.

The live presentations will be webcast and may be accessed on Neurocrine Biosciences’ website under Investors at www.neurocrine.com. A replay of the webcasts will be available on the website approximately one hour after the conclusion of the events and will be archived for approximately one month.